Related references
Note: Only part of the references are listed.The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors
Mark C. de Gooijer et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
MELK expression correlates with tumor mitotic activity but is not required for cancer growth
Christopher J. Giuliano et al.
ELIFE (2018)
MELK Inhibition in Diffuse Intrinsic Pontine Glioma
Michael H. Meel et al.
CLINICAL CANCER RESEARCH (2018)
An efficient method for the transduction of primary pediatric glioma neurospheres
Michael H. Meel et al.
METHODSX (2018)
Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies
Michael H. Meel et al.
EXPERIMENTAL CELL RESEARCH (2017)
The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity
Jeffrey A. Rubens et al.
NEURO-ONCOLOGY (2017)
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Radoslav Janostiak et al.
CELL REPORTS (2017)
CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials
Ann Lin et al.
ELIFE (2017)
SynergyFinder: a web application for analyzing drug combination dose-response matrix data
Aleksandr Ianevski et al.
BIOINFORMATICS (2017)
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
Jonathon Torchia et al.
CANCER CELL (2016)
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
Pascal D. Johann et al.
CANCER CELL (2016)
Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype
Timothy N. Phoenix et al.
CANCER CELL (2016)
Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice
Laura A. N. Peferoen et al.
IMMUNOLOGY (2016)
OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases
Wenbin Ji et al.
PLOS ONE (2016)
Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target
Melanie F. Weingart et al.
ONCOTARGET (2015)
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer
Suyoun Chung et al.
Oncotarget (2015)
Maternal Embryonic Leucine Zipper Kinase: Key Kinase for Stem Cell Phenotype in Glioma and Other Cancers
Ranjit Ganguly et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Multi-Kinase Inhibitor C1 Triggers Mitotic Catastrophe of Glioma Stem Cells Mainly through MELK Kinase Inhibition
Mutsuko Minata et al.
PLOS ONE (2014)
Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth
Kimberly H. Kim et al.
CANCER GENETICS (2014)
Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012
Irene Slavc et al.
CANCER MEDICINE (2014)
Factors Influencing the CNS Distribution of a Novel MEK-1/2 Inhibitor: Implications for Combination Therapy for Melanoma Brain Metastases
Shruthi Vaidhyanathan et al.
DRUG METABOLISM AND DISPOSITION (2014)
Maternal Embryonic Leucine Zipper Kinase (MELK): A Novel Regulator in Cell Cycle Control, Embryonic Development, and Cancer
Pengfei Jiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
Kaushal Joshi et al.
STEM CELLS (2013)
Atypical teratoid rhabdoid tumor: current therapy and future directions
Kevin F. Ginn et al.
FRONTIERS IN ONCOLOGY (2012)
Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway
Ichiro Nakano et al.
NEURO-ONCOLOGY (2011)
High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival
Diane K. Birks et al.
NEURO-ONCOLOGY (2011)
The role of SMARCB1/INI1 in development of rhabdoid tumor
Charles W. M. Roberts et al.
CANCER BIOLOGY & THERAPY (2009)
Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor
Susan N. Chi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Lin28 promotes transformation and is associated with advanced human malignancies
Srinivas R. Viswanathan et al.
NATURE GENETICS (2009)
M-phase MELK activity is regulated by MPF and MAPK
Caroline Badouel et al.
CELL CYCLE (2006)
Share Paper
